{
    "eid": "2-s2.0-84996567175",
    "title": "Population pharmacokinetics and pharmacodynamics modeling to optimize dosage regimens of sulbactam in critically ill patients with severe sepsis caused by Acinetobacter baumannii",
    "cover-date": "2016-12-01",
    "subject-areas": [
        {
            "$": "Infectious Diseases",
            "@code": "2725"
        },
        {
            "$": "Pharmacology",
            "@code": "3004"
        },
        {
            "$": "Pharmacology (medical)",
            "@code": "2736"
        }
    ],
    "keywords": [],
    "authors": [
        "Sutep Jaruratanasirikul"
    ],
    "citedby-count": 27,
    "ref-count": 29,
    "ref-list": [
        "The relationship between antimicrobial resistance and patient outcomes: Mortality, length of hospital stay, and health care costs",
        "Influence of multidrug resistance and appropriate empirical therapy on the 30-day mortality rate of Pseudomonas aeruginosa bacteremia",
        "Completely resistant Acinetobacter baumannii strains",
        "Pandrug-resistant Acinetobacter baumannii causing nosocomial infections in a University Hospital, Taiwan",
        "In Vitro Activities of the \u03b2-Lactamase Inhibitors Clavulanic Acid, Sulbactam, and Tazobactam Alone or in Combination with \u03b2-Lactams against Epidemiologically Characterized Multidrug-Resistant Acinetobacter baumannii Strains",
        "\u03b2-lactamase inhibition and in vitro activity of sulbactam and sulbactam/cefoperazone",
        "Sulbactam efficacy in experimental models caused by susceptible and intermediate Acinetobacter baumannii strains",
        "Stability of \u03b2-lactamase inhibitors and \u03b2-lactam antibiotics in parenteral dosage forms and in body fluids and tissue homogenates: A comparative study of sulbactam, clavulanic acid, ampicillin and amoxycillin",
        "Insufficient \u03b2-lactam concentrations in the early phase of severe sepsis and septic shock",
        "Subtherapeutic initial \u03b2-lactam concentrations in select critically Ill patients: Association between augmented renal clearance and low trough drug concentrations",
        "Population pharmacokinetic-pharmacodynamic target attainment analysis of sulbactam in patients with impaired renal function: Dosing considerations for Acinetobacter baumannii infections",
        "Mandell, Douglas, and Bennett's Principles and Practice of Infectious Diseases",
        "Quick bioanalytical method of quantification and validation of sulbactam in plasma using high performance liquid chromatography",
        "NONMEM Users Guide - Part V. Introductory Guide",
        "Defining covariate distribution models for clinical trial simulation",
        "Advanced Engineering Mathematics",
        "Appropriate antibiotic dosage levels in the treatment of severe sepsis and septic shock",
        "Antimicrobial Pharmacokinetic and Pharmacodynamic Issues in the Critically Ill with Severe Sepsis and Septic Shock",
        "Population pharmacokinetics of ampicillin and sulbactam in patients with community-acquired pneumonia: Evaluation of the impact of renal impairment",
        "Population Pharmacokinetics of Fixed Dose Combination of Ceftriaxone and Sulbactam in Healthy and Infected Subjects",
        "Pharmacodynamics modeling to optimize dosage regimens of sulbactam",
        "THE BINDING OF ANTIBIOTICS TO SERUM PROTEINS",
        "Interrelationship between pharmacokinetics and pharmacodynamics in determining dosage regimens for broad-spectrum cephalosporins",
        "Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model",
        "Pharmacokinetic/pharmacodynamic evaluation of sulbactam against Acinetobacter baumannii in in vitro and murine thigh and lung infection models",
        "High-dose ampicillin-sulbactam as an alternative treatment of late-onset VAP from multidrug-resistant Acinetobacter baumannii",
        "Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia",
        "Population pharmacokinetics and Monte Carlo dosing simulations of meropenem during the early phase of severe sepsis and septic shock in critically ill patients in intensive care units",
        "Pharmacodynamics of doripenem in critically ill patients with ventilator-associated Gram-negative bacilli pneumonia"
    ],
    "affiliation": [
        {
            "affiliation-city": "Hatyai",
            "affilname": "Prince of Songkla University",
            "affiliation-country": "Thailand"
        },
        {
            "affiliation-city": "Bangkok",
            "affilname": "Chulalongkorn University",
            "affiliation-country": "Thailand"
        }
    ],
    "funding": [
        "Siam Pharmaceutical Co., Ltd.",
        "Faculty of Medicine, Prince of Songkla University"
    ]
}